A number of other analysts have also recently weighed in on WBA. BidaskClub raised shares of Walgreens Boots Alliance from a sell rating to a hold rating in a research note on Wednesday, November 6th. Cleveland Research reaffirmed a hold rating on shares of Walgreens Boots Alliance in a report on Monday, September 9th. Bank of America lowered their price objective on Walgreens Boots Alliance from $51.00 to $50.00 and set an underperform rating on the stock in a research note on Thursday, October 3rd. JPMorgan Chase & Co. cut Walgreens Boots Alliance from an overweight rating to a neutral rating and dropped their target price for the stock from $73.00 to $63.00 in a report on Wednesday, October 23rd. Finally, Royal Bank of Canada lowered Walgreens Boots Alliance to a hold rating and set a $59.00 price target on the stock. in a research note on Friday, September 27th. Five investment analysts have rated the stock with a sell rating, fifteen have issued a hold rating and two have issued a buy rating to the stock. The stock has a consensus rating of Hold and an average price target of $61.35.
WBA opened at $58.99 on Tuesday. The stock’s 50 day simple moving average is $58.39 and its 200-day simple moving average is $54.41. The company has a current ratio of 0.73, a quick ratio of 0.36 and a debt-to-equity ratio of 0.46. The stock has a market cap of $53.20 billion, a PE ratio of 9.85, a P/E/G ratio of 1.49 and a beta of 0.88. Walgreens Boots Alliance has a 1 year low of $49.03 and a 1 year high of $86.31.
The business also recently declared a quarterly dividend, which will be paid on Thursday, December 12th. Investors of record on Monday, November 18th will be given a dividend of $0.458 per share. The ex-dividend date of this dividend is Friday, November 15th. This represents a $1.83 annualized dividend and a yield of 3.11%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is 30.55%.
In other news, CAO Marco Patrick Anthony Pagni sold 234,355 shares of the stock in a transaction that occurred on Tuesday, November 5th. The shares were sold at an average price of $63.16, for a total transaction of $14,801,861.80. Following the sale, the chief accounting officer now directly owns 13,844 shares of the company’s stock, valued at $874,387.04. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 15.73% of the stock is owned by corporate insiders.
Several hedge funds and other institutional investors have recently modified their holdings of the company. NEXT Financial Group Inc boosted its stake in Walgreens Boots Alliance by 27.8% in the second quarter. NEXT Financial Group Inc now owns 2,663 shares of the pharmacy operator’s stock valued at $145,000 after acquiring an additional 580 shares during the last quarter. Westside Investment Management Inc. acquired a new stake in shares of Walgreens Boots Alliance during the second quarter worth $83,000. Manning & Napier Group LLC grew its stake in shares of Walgreens Boots Alliance by 35.7% during the second quarter. Manning & Napier Group LLC now owns 296,883 shares of the pharmacy operator’s stock worth $16,230,000 after purchasing an additional 78,025 shares during the period. Trustcore Financial Services LLC increased its holdings in Walgreens Boots Alliance by 592.0% in the second quarter. Trustcore Financial Services LLC now owns 3,384 shares of the pharmacy operator’s stock valued at $185,000 after purchasing an additional 2,895 shares during the last quarter. Finally, Sumitomo Life Insurance Co. increased its holdings in Walgreens Boots Alliance by 2.7% in the second quarter. Sumitomo Life Insurance Co. now owns 18,386 shares of the pharmacy operator’s stock valued at $1,005,000 after purchasing an additional 488 shares during the last quarter. 60.10% of the stock is currently owned by institutional investors.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.